Skip to main navigation Skip to search Skip to main content

Report of optic disc edema in growth hormone insensitive patients after treatment with insulin-like growth factor-I

  • Jaime Guevara-Aguirre
  • , Ramiro Maldonado
  • , Elizabeth A. Koller*
  • , V. Martinez
  • , O. Vasconez
  • , Saul N. Malozowski
  • *Corresponding author for this work
  • Inst. Endocrinol.
  • Center for Drug Evaluation
  • U. S. Food and Drug Administration

Research output: Contribution to journalArticlepeer-review

Abstract

Intracranial hypertension with papilledema has recently been reported with growth hormone administration. We present the case of a 14 year old female with growth hormone insensitivity syndrome (GHIS), who developed optic disc edema (ODE) within 30 days of the initiation of therapy with recombinant IGF-I (insulin-like growth factor I) (120 μg/kg BID). Symptoms may be intermittent, and thereby unreliable indicators of ODE. At least 5/131 patients with GHIS who have received IGF-I have developed this condition. Because of the high risk for developing ODE in this patient population, serial funduscopic examination is warranted for children receiving IDF-I.

Original languageEnglish
Pages (from-to)384-391
Number of pages8
JournalAnnals of Ophthalmology - Glaucoma
Volume29
Issue number6
StatePublished - Nov 1997
Externally publishedYes

Fingerprint

Dive into the research topics of 'Report of optic disc edema in growth hormone insensitive patients after treatment with insulin-like growth factor-I'. Together they form a unique fingerprint.

Cite this